COVID-19 rapid guideline: rheumatological autoimmune, inflammatory and metabolic bone disorders – guidance (NG167)

The purpose of this guideline is to maximise the safety of children and adults with rheumatological autoimmune, inflammatory and metabolic bone disorders during the COVID-19 pandemic, while protecting staff from infection.

Source:

National Institute for Health and Care Excellence